Human rhinovirus cell entry and uncoating

Structure-Based Study of Viral Replication: (With CD-Rom)

Volumn , Issue , 2008, Pages 1-41

  Fuchs, Renate ^a   Blaas, Dieter ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAX F PERUTZ LABORATORIES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969135681     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812790859_0001     Document Type: Chapter

References (140)

1. Tyrell AD, Fielder M. (2003) Cold wars. The fight against the common cold. Oxford University Press.
2. Lewis JK, Bothner B, Smith TJ, Siuzdak G. (1998) Antiviral agent blocks breathing of the common cold virus. Proc Natl Acad Sci USA 95: 6774-6778.
3. Phelps DK, Post CB. (1999) Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus. Protein Sci 8: 2281-2289.
4. Phelps DK, Rossky PJ, Post CB. (1998) Influence of an antiviral compound on the temperature dependence of viral protein flexibility and packing: a molecular dynamics study. J Mol Biol 276: 331-337.
5. Reisdorph N, Thomas JJ, Katpally U, et al. (2003) Human rhinovirus capsid dynamics is controlled by canyon flexibility. Virology 314: 34-44.
6. Speelman B, Brooks BR, Post CB. (2001) Molecular dynamics simulations of human rhinovirus and an antiviral compound. Biophys J 80: 121-129.
7. Lonberg-Holm K, Crowell RL, Philipson L. (1976) Unrelated animal viruses share receptors. Nature 259: 679-681.
8. Lonberg-Holm K, Gosser LB, Shimshick J. (1976) Interaction of liposomes with subviral particles of poliovirus type 2 and rhinovirus type 2. J Virol 19: 746-749.
9. Abraham G, Colonno RJ. (1984) Many rhinovirus serotypes share the same cellular receptor. J Virol 51: 340-345.
10. Colonno RJ, Callahan PL, Long WJ. (1986) Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J Virol 57: 7-12.
11. Tomassini JE, Colonno RJ. (1986) Isolation of a receptor protein involved in attachment of human rhinoviruses. J Virol 58: 290-295.
12. Greve JM, Davis G, Meyer AM, et al. (1989) The major human rhinovirus receptor is ICAM-1. Cell 56: 839-847.
13. Staunton DE, Merluzzi VJ, Rothlein R, et al. (1989) A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56: 849-853.
14. Tomassini E, Graham T, DeWitt C, et al. (1989) cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci USA 86: 4907-4911.
15. Gruenberger M, Wandl R, Nimpf J, et al. (1995) Avian homologs of the mammalian low-density lipoprotein receptor family bind minor receptor group human rhinovirus. J Virol 69: 7244-7247.
16. Hofer F, Gruenberger M, Kowalski H, et al. (1994) Members of the low density lipoprotein receptor family mediate cell entry of a minorgroup common cold virus. Proc Nat Acad Sci USA 91: 1839-1842.
17. Marlovits TC, Abrahamsberg C, Blaas D. (1998) Soluble LDL minireceptors. Minimal structure requirements for recognition of minor group human rhinovirus. J Biol Chem 273: 33835-33840.
18. Marlovits TC, Abrahamsberg C, Blaas D. (1998) Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection. J Virol 72: 10246-10250.
19. Blomqvist S, Savolainen C, Raman L, et al. (2002) Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol 40: 4218-4223.
20. Laine P, Savolainen C, Blomqvist S, Hovi T. (2005) Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J Gen Virol 86: 697-706.
21. Savolainen C, Laine P, Mulders MN, Hovi T. (2004) Sequence analysis of human rhinoviruses in the RNA-dependent RNA polymerase coding region reveals large within-species variation. J Gen Virol 85: 2271-2277.
22. Vlasak M, Roivainen M, Reithmayer M, et al. (2005) The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol 79: 7389-7395.
23. Ledford RM, Patel NR, Demenczuk TM, et al. (2004) VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol 78: 3663-3674.
24. McKinlay MA, Pevear DC, Rossmann MG. (1992) Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Ann Rev Microbiol 46: 635-654.
25. Kim KH, Willingmann P, Gong ZX, et al. (1993) A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. J Mol Biol 230: 206-227.
26. Andries K, Dewindt B, Snoeks J, et al. (1990) Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol 64: 1117-1123.
27. Verdaguer N, Blaas D, Fita I. (2000) Structure of human rhinovirus serotype 2 (HRV2). J Mol Biol 300: 1179-1194.
28. Gruenberger M, Pevear D, Diana GD, et al. (1991) Stabilization of human rhinovirus serotype-2 against pH-induced conformational change by antiviral compounds. J Gen Virol 72: 431-433.
29. Okun VM, Nizet S, Blaas D, Kenndler E. (2002) Kinetics of thermal denaturation of human rhinoviruses in the presence of anti-viral capsid binders analyzed by capillary electrophoresis. Electrophoresis 23: 896-902.
30. Zhang AQ, Nanni RG, Li T, et al. (1993) Structure determination of antiviral compound SCH-38057 complexed with human rhinovirus-14. J Mol Biol 230: 857-867.
31. Rossmann MG. (1994) Viral cell recognition and entry. Protein Sci 3: 1712-1725.
32. Savolainen C, Blomqvist S, Mulders MN, Hovi T. (2002) Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J Gen Virol 83: 333-340.
33. Sherry B, Mosser AG, Colonno J, Rueckert RR. (1985) Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus human rhinovirus 14. J Virol 57: 246-257.
34. Sherry B, Rueckert R. (1985) Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol 53: 137-143.
35. Rossmann MG. (1989) The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. J Biol Chem 264: 14587-14590.
36. Olson NH, Kolatkar PR, Oliveira MA, et al. (1993) Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci USA 90: 507-511.
37. Chapman MS, Rossmann MG. (1993) Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance. Virology 195: 745-756.
38. 37a. Laine P, Blomqvist S, Savolainen C, et al. (2006) Alignment of capsid protein VP1 sequnces of all human rhinovirus prototype strains: conserved motifs and functional domains. J Gen Virol 8: 129-138.
39. Smith TJ, Chase ES, Schmidt TJ, et al. (1996) Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature 383: 350-354.
40. Kim S, Smith TJ, Chapman MS, et al. (1989) Crystal structure of human rhinovirus serotype-1A (HRV1A). J Mol Biol 210: 91-111.
41. Oliveira MA, Zhao R, Lee WM, et al. (1993) The structure of human rhinovirus 16. Structure 1: 51-68.
42. Rossmann M, Arnold E, Erickson J, et al. (1985) Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317: 145-153.
43. Zhao R, Pevear DC, Kremer MJ, et al. (1996) Human rhinovirus 3 at 3.0 angstrom resolution. Structure 4: 1205-1220.
44. Bella J, Kolatkar PR, Marlor CW, et al. (1998) The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci USA 95: 4140-4145.
45. Rudenko G, Deisenhofer J. (2003) The low-density lipoprotein receptor: ligands, debates and lore. Curr Opin Struct Biol 13: 683-689.
46. Staunton DE, Dustin ML, Erickson HP, Springer TA. (1990) The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 61: 243-254.
47. Rothlein R, Dustin ML, Marlin SD, Springer TA. (1986) A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137: 1270-1274.
48. Casasnovas JM, Bickford JK, Springer TA. (1998) The domain structure of ICAM-1 and the kinetics of binding to rhinovirus. J Virol 72: 6244-6246.
49. Fass D, Blacklow S, Kim PS, Berger JM. (1997) Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 388: 691-693.
50. Rudenko G, Henry L, Henderson K, et al. (2002) Structure of the LDL receptor extracellular domain at endosomal pH. Science 298: 2353-2358.
51. Russell DW, Schneider WJ, Yamamoto T, et al. (1984) Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor. Cell 37: 577-585.
52. Strickland DK, Kounnas MZ, Williams SE, Argraves WS. (1994) LDL receptor-related protein (LRP): a multiligand receptor. Fibrinolysis 8: 204-215.
53. Bhella D, Goodfellow IG, Roversi P, et al. (2004) The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55). J Biol Chem 279: 8325-8332.
54. He Y, Bowman VD, Mueller S, et al. (2000) Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci USA 97: 79-84.
55. He Y, Chipman PR, Howitt J, et al. (2001) Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 8: 874-878.
56. Neumann E, Moser R, Snyers L, et al. (2003) A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid. J Virol 77: 8504-8511.
57. Xing L, Huhtala M, Pietiainen V, et al. (2004) Structural and functional analysis of integrin alpha2I domain interaction with echovirus 1. J Biol Chem 279: 11632-11638.
58. Xiao C, Tuthill TJ, Bator Kelly CM, et al. (2004) Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule. J Virol 78: 10034-10044.
59. Verdaguer N, Fita I, Reithmayer M, et al. (2004) X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein. Nat Struct Mol Biol 11: 429-434.
60. Xiao C, Bator CM, Bowman VD, et al. (2001) Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1. J Virol 75: 2444-2451.
61. Moser R, Wruss J, Snyers L, et al. (2005) Concatenation of VDLreceptor ligand-binding repeat 3 results in highly efficient inhibitors of HRV infection: evidence for multi-module binding. Submitted.
62. 60a. Wruss J, Runzler D, Steiger C, et al. (2007) Attachment of VLDL receptors to an icosahedral virus along the 5-fold symmetry axis: multiple binding modes evidenced by fluorescence correlation spectroscopy. Biochemistry 46: 6331-6339.
63. Conner SD, Schmid SL. (2003) Regulated portals of entry into the cell. Nature 422: 37-44.
64. Pelkmans L, Helenius A. (2003) Insider information: what viruses tell us about endocytosis. Curr Opin Cell Biol 15: 414-422.
65. Damm EM, Pelkmans L, Kartenbeck J, et al. (2005) Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 168: 477-488.
66. Hansen SH, Sandvig K, van Deurs B. (1993) Molecules internalized by clathrin-independent endocytosis are delivered to endosomes containing transferrin receptors. J Cell Biol 123: 89-97.
67. Pelkmans L, Burli T, Zerial M, Helenius A. (2004) Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118: 767-780.
68. Mukherjee S, Ghosh RN, Maxfield FR. (1997) Endocytosis. Physiol Rev 77: 759-803.
69. Nishi T, Forgac M. (2002) The vacuolar (H)-ATPases - nature’s most versatile proton pumps. Nat Rev Mol Cell Biol 3: 94-103.
70. Mellman I, Fuchs R, Helenius A. (1986) Acidification of the endocytic and exocytic pathways. Ann Rev Biochem 55: 663-700.
71. Fuchs R, Ellinger A, Pavelka M, et al. (1994) Rat liver endocytic coated vesicles do not exhibit ATP-dependent acidification in vitro. Proc Nat Acad Sci USA 91: 4811-4815.
72. Bayer N, Schober D, Prchla E, et al. (1998) Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J Virol 72: 9645-9655.
73. Clague MJ. (1998) Molecular aspects of the endocytic pathway. Biochem J 336: 271-282.
74. Raiborg C, Rusten TE, Stenmark H. (2003) Protein sorting into multivesicular endosomes. Curr Opin Cell Biol 15: 446-455.
75. Baravalle G, Schober D, Huber M, et al. (2005) Transferrin recycling and dextran transport to lysosomes is differentially affected by bafilomycin, nocodazole, and low temperature. Cell Tissue Res 320: 99-113.
76. Sonawane ND, Verkman AS. (2003) Determinants of [Cl-] in recycling and late endosomes and Golgi complex measured using fluorescent ligands. J Cell Biol 160: 1129-1138.
77. Aniento F, Emans N, Griffiths G, Gruenberg J. (1993) Cytoplasmic dynein-dependent vesicular transport from early to late endosomes. J Cell Biol 123: 1373-1387.
78. Griffiths G, Hoflack B, Simons K, et al. (1988) The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52: 329-341.
79. Maxfield FR, McGraw TE. (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5: 121-132.
80. Ghosh RN, Gelman DL, Maxfield FR. (1994) Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy. J Cell Sci 107: 2177-2189.
81. Sheff DR, Daro EA, Hull M, Mellman I. (1999) The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J Cell Biol 145: 123-139.
82. Staunton DE, Gaur A, Chan PY, Springer TA. (1992) Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1. J Immunol 148: 3271-3274.
83. DeTulleo L, Kirchhausen T. (1998) The clathrin endocytic pathway in viral infection. EMBO J 17: 4585-4593.
84. Meier O, Greber UF. (2003) Adenovirus endocytosis. J Gene Med 5: 451-462.
85. Casasnovas M, Springer TA. (1995) Kinetics and thermodynamics of virus binding to receptor. Studies with rhinovirus, intercellular adhesion molecule-1 (ICAM-1), and surface plasmon resonance. J Biol Chem 270: 13216-13224.
86. Schober D, Kronenberger P, Prchla E, et al. (1998) Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J Virol 72: 1354-1364.
87. Lonberg-Holm K, Korant BD. (1972) Early interaction of rhinoviruses with host cells. J Virol 9: 29-40.
88. Strickland DK, Gonias SL, Argraves WS. (2002) Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13: 66-74.
89. Bayer N, Schober D, Hüttinger M, et al. (2001) Inhibition of clathrindependent endocytosis has multiple effects on HRV2 cell entry. J Biol Chem 276: 3952-3962.
90. Huber M, Brabec M, Bayer N, et al. (2001) Elevated endosomal pH in HeLa cells overexpressing mutant dynamin can affect infection by pH-sensitive viruses. Traffic 2: 727-736.
91. Madshus IH, Sandvig K, Olsnes S, van Deurs B. (1987) Effect of reduced endocytosis induced by hypotonic shock and potassium depletion on the infection of Hep 2 cells by picornaviruses. J Cell Physiol 131: 14-22.
92. Snyers L, Zwickl H, Blaas D. (2003) Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis. J Virol 77: 5360-5369.
93. Brabec M, Baravalle G, Blaas D, Fuchs R. (2003) Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH. J Virol 77: 5370-5377.
94. Prchla E, Kuechler E, Blaas D, Fuchs R. (1994) Uncoating of human rhinovirus serotype 2 from late endosomes. J Virol 68: 3713-3723.
95. Casasnovas JM, Springer TA. (1994) Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J Virol 68: 5882-5889.
96. Korant BD, Lonberg-Holm K, Noble J, Stasny JT. (1972) Naturally occurring and artificially produced components of three rhinoviruses. Virology 48: 71-86.
97. Lonberg-Holm K, Noble-Harvey J. (1973) Comparison of in vitro and cell-mediated alteration of a human rhinovirus and its inhibition by sodium dodecyl sulfate. J Virol 12: 819-824.
98. Lonberg-Holm K, Yin FH. (1973) Antigenic determinants of infective and inactivated human rhinovirus type 2. J Virol 12: 114-123.
99. Noble JN, Lonberg-Holm K. (1973) Interactions of components of human rhinovirus type 2 with HeLa cells. Virology 51: 270-278.
100. Neubauer C, Frasel L, Kuechler E, Blaas D. (1987) Mechanism of entry of human rhinovirus 2 into HeLa cells. Virology 158: 255-258.
101. Hewat EA, Blaas D. (2004) Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating. J Virol 78: 2935-2942.
102. Hewat EA, Neumann E, Blaas D. (2002) The concerted conformational changes during human rhinovirus 2 uncoating. Mol Cell 10: 317-326.
103. Xing L, Casasnovas JM, Cheng RH. (2003) Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating. J Virol 77: 6101-6107.
104. Greve J, Forte C, Marlor C, et al. (1991) Mechanisms of receptormediated rhinovirus neutralization defined by two soluble forms of ICAM-1. J Virol 65: 6015-6023.
105. Hoover-Litty H, Greve JM. (1993) Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J Virol 67: 390-397.
106. Nurani G, Lindqvist B, Casasnovas JM. (2003) Receptor priming of major group human rhinoviruses for uncoating and entry at mild lowpH environments. J Virol 77: 11985-11991.
107. Casasnovas JM. (2000) The dynamics of receptor recognition by human rhinoviruses. Trends Microbiol 8: 251-254.
108. Rossmann MG, Bella J, Kolatkar PR, et al. (2000) Cell recognition and entry by rhino- and enteroviruses. Virology 269: 239-247.
109. Xing L, Tjarnlund K, Lindqvist B, et al. (2000) Distinct cellular receptor interactions in poliovirus and rhinoviruses. EMBO J 19: 1207-1216.
110. Tsang SK, McDermott BM, Racaniello VR, Hogle JM. (2001) Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J Virol 75: 4984-4989.
111. Bayer N, Prchla E, Schwab M, et al. (1999) Human rhinovirus HRV14 uncoats from early endosomes in the presence of bafilomycin. FEBS Lett 463: 175-178.
112. Perez L, Carrasco L. (1993) Entry of poliovirus into cells does not require a low-pH step. J Virol 67: 4543-4548.
113. Lee WM, Monroe SS, Rueckert RR. (1993) Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol 67: 2110-2122.
114. Baravalle G, Snyers L, Brabec M, et al. (2004) Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1. J Virol 78: 2729-2735.
115. Brabec M, Schober D, Wagner E, et al. (2005) Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis. J Virol 79: 1008-1016.
116. Danthi P, Tosteson M, Li QH, Chow M. (2003) Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus. J Virol 77: 5266-5274.
117. Hogle JM. (2002) Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol 56: 677-702.
118. Tosteson MT, Chow M. (1997) Characterization of the ion channels formed by poliovirus in planar lipid membranes. J Virol 71: 507-511.
119. Belnap DM, Filman DJ, Trus BL, et al. (2000) Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol 74: 1342-1354.
120. Bubeck D, Filman DJ, Hogle JM. (2005) Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex. Nat Struct Mol Biol 12: 615-618.
121. Kirkegaard K. (1990) Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J Virol 64: 195-206.
122. Moscufo N, Yafal A, Rogove A, et al. (1993) A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus. J Virol 67: 5075-5078.
123. Prchla E, Plank C, Wagner E, et al. (1995) Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2. J Cell Biol 131: 111-123.
124. Schober D, Bayer N, Murphy RF, et al. (1999) Establishment of an assay to determine adenovirus-induced endosome rupture required for receptor-mediated gene delivery. Gene Ther Mol Biol 3: 25-33.
125. Parente RA, Nir S, Szoka FCJ. (1990) Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry 29: 8720-8728.
126. Kienberger F, Zhu R, Moser R, et al. (2004) Monitoring RNA release from human rhinovirus by dynamic force microscopy. J Virol 78: 3203-3209.
127. Kuznetsov YG, Daijogo S, Zhou J, et al. (2005) Atomic force microscopy analysis of icosahedral virus RNA. J Mol Biol 347: 41-52.
128. Winther B, Gwaltney JM, Jr., Mygind N, et al. (1986) Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 256: 1763-1767.
129. Hayden FG. (2004) Rhinovirus and the lower respiratory tract. Rev Med Virol 14: 17-31.
130. Mosser AG, Brockman-Schneider R, Amineva S, et al. (2002) Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis 185: 734-743.
131. Pitkaranta A, Hayden FG. (1998) Rhinoviruses: important respiratory pathogens. Ann Med 30: 529-537.
132. Pitkaranta A, Puhakka T, Makela MJ, et al. (2003) Detection of rhinovirus RNA in middle turbinate of patients with common colds by in situ hybridization. J Med Virol 70: 319-323.
133. Knight DA, Holgate ST. (2003) The airway epithelium: structural and functional properties in health and disease. Respirology 8: 432-446.
134. Demoly P, Sahla M, Campbell AM, et al. (1998) ICAM-1 expression in upper respiratory mucosa is differentially related to eosinophil and neutrophil inflammation according to the allergic status. Clin Exp Allergy 28: 731-738.
135. Papon JF, Coste A, Gendron MC, et al. (2002) HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps. Laryngoscope 112: 2067-2075.
136. Winther B, Greve JM, Gwaltney JM, et al. (1997) Surface expression of intercellular adhesion molecule 1 on epithelial cells in the human adenoid. J Infect Diseases 176: 523-525.
137. Taguchi M, Sampath D, Koga T, et al. (1998) Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med 187: 1927-1940.
138. Lopez-Souza N, Dolganov G, Dubin R, et al. (2004) Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 286: L373-381.
139. Suzuki T, Yamaya M, Kamanaka M, et al. (2001) Type 2 rhinovirus infection of cultured human tracheal epithelial cells: role of LDL receptor. Am J Physiol Lung Cell Mol Physiol 280: L409-420.
140. Suzuki T, Yamaya M, Sekizawa K, et al. (2001) Bafilomycin A(1) inhibits rhinovirus infection in human airway epithelium: effects on endosome and ICAM-1. Am J Physiol Lung Cell Mol Physiol 280: L1115-1127.